COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA

INTRODUCTION: Bevacizumab (BEV) therapy has been used for pediatric high grade glioma,however the evidence and effectiveness are not understood yet. METHODS: We report 7 cases (age 2 to 10 years old) of pediatric high grade glioma treated with BEV. One case is thalamic diffuse midline glioma H3K27 m...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neurooncol Adv
Main Authors: Tsukamoto, Yoshihiro, Natsumeda, Manabu, Okada, Masayasu, Eda, Takeyoshi, Yoshimura, Junichi, Okamoto, Kouichirou, Oishi, Makoto, Fujii, Yukihiko
格式: Artigo
語言:Inglês
出版: Oxford University Press 2019
主題:
Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213162/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.201
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍